Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXTENZA Intraocular Levels in Vitrectomy
NCT04529512Phase 4Unknown
- Start
- Mar 2021
- Primary completion
- Mar 2021
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in post-operative ocular pain, post-operative ocular inflammation. Status: unknown.
02
Drugs
ozurdex
03
Conditions
post-operative ocular painpost-operative ocular inflammation
Beyond the preview
Go deeper on NCT04529512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04529512.